Phase 3 Leukocyte Adhesion Deficiency Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects With Leukocyte Adhesion Deficiency Type II
Leukocyte Adhesion Deficiency
AUG Therapeutics2 enrolled1 locationNCT05754450
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients With Leukocyte Adhesion Deficiency Type II
Leukocyte Adhesion Deficiency
AUG Therapeutics4 enrolled1 locationNCT05462587